A comprehensive review and update on Crohn's disease

M Gajendran, P Loganathan, AP Catinella… - Disease-a-month, 2018 - Elsevier
The term inflammatory bowel disease (IBD) refers principally to two major categories of
chronic relapsing inflammatory intestinal disorders: Crohn's disease (CD) and ulcerative …

Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice

C Berna, RJ Kulich, JP Rathmell - Mayo clinic proceedings, 2015 - Elsevier
Increasing concern about the risks and limited evidence supporting the therapeutic benefit of
long-term opioid therapy for chronic noncancer pain are leading prescribers to consider …

Opioid tolerance in critical illness

JAJ Martyn, J Mao, EA Bittner - New England Journal of Medicine, 2019 - Mass Medical Soc
Opioid Tolerance in Critical Illness | NEJM Skip to main content NEJM Group Follow Us
Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your …

Distinct profiles of functional discrimination among G proteins determine the actions of G protein–coupled receptors

I Masuho, O Ostrovskaya, GM Kramer, CD Jones… - Science …, 2015 - science.org
Members of the heterotrimeric guanine nucleotide–binding protein (G protein)–coupled
receptor (GPCR) family play key roles in many physiological functions and are extensively …

[HTML][HTML] Prevention of opioid overdose

KM Babu, J Brent, DN Juurlink - New England Journal of …, 2019 - Mass Medical Soc
Prevention of Opioid Overdose This review explains harm-reduction strategies for three
groups of patients: those who have not received previous opioid therapy, those receiving …

Etiology and treatment of pain and psychosocial issues in patients with inflammatory bowel diseases

M Regueiro, JB Greer, E Szigethy - Gastroenterology, 2017 - Elsevier
There is increasing evidence that brain− gut interactions are altered during development of
inflammatory bowel diseases (IBDs). Understanding the relationship between the …

Changes in buprenorphine-naloxone and opioid pain reliever prescriptions after the Affordable Care Act Medicaid expansion

B Saloner, J Levin, HY Chang, C Jones… - JAMA network …, 2018 - jamanetwork.com
Importance Expanding Medicaid eligibility could affect prescriptions of buprenorphine with
naloxone, an established treatment for opioid use disorder, and opioid pain relievers …

To stop or not, that is the question: acute pain management for the patient on chronic buprenorphine

TA Anderson, ANA Quaye, EN Ward, TE Wilens… - …, 2017 - pubs.asahq.org
To Stop or Not, That Is the Question | Anesthesiology | American Society of
Anesthesiologists Skip to Main Content Advertisement Umbrella Alt Text Umbrella Alt Text …

Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review

LA Spreen, EN Dittmar, KC Quirk… - … : The Journal of Human …, 2022 - Wiley Online Library
Buprenorphine possesses many unique attributes that make it a practical agent for adults
and adolescents with opioid use disorder (OUD) and/or acute or chronic pain. Sublingual …

Identifying individuals with opioid use disorder: validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse

P Lagisetty, C Garpestad, A Larkin, C Macleod… - Drug and alcohol …, 2021 - Elsevier
Background Policy evaluations and health system interventions often utilize International
Classification of Diseases (ICD) codes of opioid use, dependence, and abuse to identify …